$11 Billion is the total value of Orbimed Advisors's 130 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 12.1% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $577,492,000 | +12.5% | 8,395,000 | -3.2% | 5.23% | +0.9% |
| AMGN | Sell | AMGEN INC | $474,166,000 | +13.8% | 2,921,000 | -3.1% | 4.29% | +2.1% |
| BSX | Buy | BOSTON SCIENTIFIC CORP | $450,506,000 | +14.4% | 24,430,900 | +1.8% | 4.08% | +2.6% |
| AGN | Sell | ALLERGAN PLC | $445,223,000 | +13.5% | 1,424,715 | -1.3% | 4.03% | +1.8% |
| BIIB | Buy | BIOGEN INC | $441,910,000 | +15.8% | 1,442,500 | +10.3% | 4.00% | +3.9% |
| ABBV | Buy | ABBVIE INC | $441,249,000 | +16.8% | 7,448,500 | +7.3% | 4.00% | +4.8% |
| CELG | Buy | CELGENE CORP | $438,974,000 | +12.9% | 3,665,450 | +2.0% | 3.98% | +1.3% |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $433,975,000 | +24.6% | 2,275,100 | +2.2% | 3.93% | +11.8% |
| HCA | Buy | HCA HOLDINGS INC | $402,777,000 | -10.8% | 5,955,600 | +2.0% | 3.65% | -20.0% |
| GILD | Buy | GILEAD SCIENCES INC | $346,211,000 | +61.4% | 3,421,400 | +56.6% | 3.14% | +44.8% |
| INCY | Buy | INCYTE CORP | $307,236,000 | +1.6% | 2,832,978 | +3.4% | 2.78% | -8.9% |
| IPXL | IMPAX LABORATORIES INC | $284,957,000 | +21.4% | 6,664,100 | 0.0% | 2.58% | +8.9% | |
| REGN | Sell | REGENERON PHARMACEUTICALS | $262,206,000 | +15.6% | 483,000 | -1.0% | 2.37% | +3.7% |
| RLYP | RELYPSA INC | $209,716,000 | +53.1% | 7,400,000 | 0.0% | 1.90% | +37.3% | |
| HNT | Sell | HEALTH NET INC | $204,613,000 | -0.0% | 2,988,800 | -12.0% | 1.85% | -10.3% |
| WMGI | New | WRIGHT MED GROUP N V | $199,367,000 | – | 8,245,111 | +100.0% | 1.80% | – |
| TMO | Buy | THERMO FISHER SCIENTIFIC INC | $195,753,000 | +17.4% | 1,380,000 | +1.2% | 1.77% | +5.3% |
| ESRX | Buy | EXPRESS SCRIPTS HLDG CO | $190,729,000 | +75.5% | 2,182,000 | +62.6% | 1.73% | +57.4% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $175,524,000 | +94.8% | 2,238,825 | +87.3% | 1.59% | +74.8% |
| MYL | New | MYLAN N V | $170,699,000 | – | 3,157,000 | +100.0% | 1.55% | – |
| ILMN | Sell | ILLUMINA INC | $168,336,000 | -16.8% | 877,000 | -23.8% | 1.52% | -25.4% |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $167,272,000 | -10.0% | 1,120,000 | 0.0% | 1.52% | -19.2% | |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $160,555,000 | +29.3% | 2,446,000 | +11.2% | 1.45% | +16.0% |
| OPHT | Buy | OPHTHOTECH CORP | $157,963,000 | +102.7% | 2,011,500 | +4.6% | 1.43% | +81.7% |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $142,272,000 | -6.3% | 2,514,974 | -34.1% | 1.29% | -16.0% |
| A | Sell | AGILENT TECHNOLOGIES INC | $139,060,000 | +14.5% | 3,326,000 | -6.0% | 1.26% | +2.7% |
| LLY | Buy | LILLY ELI & CO | $135,911,000 | +27.7% | 1,613,000 | +26.8% | 1.23% | +14.5% |
| PFE | Buy | PFIZER INC | $133,123,000 | +12.6% | 4,124,000 | +9.6% | 1.20% | +1.0% |
| ISRG | INTUITIVE SURGICAL INC | $130,532,000 | +18.8% | 239,000 | 0.0% | 1.18% | +6.6% | |
| IRWD | IRONWOOD PHARMACEUTICALS INC | $130,114,000 | +11.2% | 11,226,400 | 0.0% | 1.18% | -0.3% | |
| INSYQ | Buy | INSYS THERAPEUTICS INC NEW | $125,020,000 | +7.6% | 4,366,740 | +7.0% | 1.13% | -3.5% |
| COO | Sell | COOPER COS INC | $122,780,000 | -36.6% | 914,900 | -29.7% | 1.11% | -43.1% |
| MGLN | MAGELLAN HEALTH INC | $113,023,000 | +11.2% | 1,833,000 | 0.0% | 1.02% | -0.3% | |
| AGNPRA | ALLERGAN PLCpfd conv ser a | $107,221,000 | +9.1% | 104,200 | 0.0% | 0.97% | -2.1% | |
| WCG | Buy | WELLCARE HEALTH PLANS INC | $105,286,000 | +971.6% | 1,346,200 | +1080.9% | 0.95% | +862.6% |
| ACHN | Buy | ACHILLION PHARMACEUTICALS IN | $104,122,000 | +188.5% | 9,649,900 | +84.8% | 0.94% | +159.1% |
| MNKKQ | Buy | MALLINCKRODT PUB LTD CO | $94,183,000 | +25.6% | 1,262,000 | +7.6% | 0.85% | +12.7% |
| TSRO | Buy | TESARO INC | $92,329,000 | +32.7% | 1,764,700 | +1.7% | 0.84% | +19.1% |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEW | $89,730,000 | -22.9% | 3,382,200 | +24.3% | 0.81% | -30.7% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $84,684,000 | +607.1% | 673,000 | +485.2% | 0.77% | +533.9% |
| IMGN | Buy | IMMUNOGEN INC | $82,718,000 | +139.7% | 6,095,647 | +69.6% | 0.75% | +115.2% |
| NUVA | NUVASIVE INC | $80,462,000 | +12.2% | 1,487,000 | 0.0% | 0.73% | +0.7% | |
| AFFX | AFFYMETRIX INC | $75,786,000 | +18.1% | 7,511,000 | 0.0% | 0.69% | +5.9% | |
| GKOS | GLAUKOS CORP | $71,550,000 | +2.1% | 2,897,937 | 0.0% | 0.65% | -8.5% | |
| MCK | Sell | MCKESSON CORP | $68,907,000 | -46.8% | 349,372 | -50.1% | 0.62% | -52.3% |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $66,972,000 | +59.6% | 1,301,700 | +32.2% | 0.61% | +42.9% |
| INSM | Buy | INSMED INC | $62,979,000 | +7.8% | 3,469,900 | +10.3% | 0.57% | -3.4% |
| LOXO | LOXO ONCOLOGY INC | $61,903,000 | +62.8% | 2,175,857 | 0.0% | 0.56% | +46.1% | |
| DMTX | New | DIMENSION THERAPEUTICS INC | $60,886,000 | – | 5,397,698 | +100.0% | 0.55% | – |
| BLUE | Sell | BLUEBIRD BIO INC | $60,476,000 | -40.5% | 941,700 | -20.8% | 0.55% | -46.6% |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $59,728,000 | -1.5% | 2,472,200 | 0.0% | 0.54% | -11.6% | |
| SHPG | Sell | SHIRE PLCsponsored adr | $51,449,000 | -62.3% | 250,971 | -62.2% | 0.47% | -66.1% |
| OTIC | Sell | OTONOMY INC | $51,340,000 | +27.8% | 1,850,094 | -18.0% | 0.46% | +14.5% |
| MDT | MEDTRONIC PLC | $45,252,000 | +14.9% | 588,299 | 0.0% | 0.41% | +3.0% | |
| ARRY | Buy | ARRAY BIOPHARMA INC | $45,108,000 | -1.7% | 10,689,000 | +6.2% | 0.41% | -11.9% |
| CI | New | CIGNA CORPORATION | $41,265,000 | – | 282,000 | +100.0% | 0.37% | – |
| CERS | CERUS CORP | $41,108,000 | +39.2% | 6,504,400 | 0.0% | 0.37% | +24.8% | |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $39,644,000 | +34.7% | 390,000 | +136.4% | 0.36% | +20.9% |
| NLNK | Buy | NEWLINK GENETICS CORP | $34,764,000 | +36.2% | 955,306 | +34.1% | 0.32% | +22.1% |
| INFI | INFINITY PHARMACEUTICALS INC | $34,668,000 | -7.1% | 4,416,300 | 0.0% | 0.31% | -16.7% | |
| MOH | Sell | MOLINA HEALTHCARE INC | $34,205,000 | -84.6% | 568,850 | -82.4% | 0.31% | -86.2% |
| AFMD | AFFIMED N V | $32,628,000 | +15.4% | 4,582,616 | 0.0% | 0.30% | +3.5% | |
| XNPT | XENOPORT INC | $31,669,000 | +58.2% | 5,768,400 | 0.0% | 0.29% | +42.1% | |
| JNJ | JOHNSON & JOHNSON | $29,994,000 | +10.0% | 292,000 | 0.0% | 0.27% | -1.1% | |
| DNAI | PRONAI THERAPEUTICS INC | $29,929,000 | -26.7% | 1,989,949 | 0.0% | 0.27% | -34.2% | |
| UNH | UNITEDHEALTH GROUP INC | $27,998,000 | +1.4% | 238,000 | 0.0% | 0.25% | -9.0% | |
| FLDM | FLUIDIGM CORP DEL | $26,483,000 | +33.3% | 2,449,900 | 0.0% | 0.24% | +19.4% | |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $25,536,000 | -74.9% | 729,600 | -34.0% | 0.23% | -77.5% |
| GWPH | Sell | GW PHARMACEUTICALS PLCads | $21,117,000 | -38.7% | 304,100 | -19.4% | 0.19% | -45.1% |
| PRQR | Buy | PROQR THRAPEUTICS N V | $19,717,000 | -26.5% | 2,271,500 | +23.4% | 0.18% | -33.9% |
| FWP | FORWARD PHARMA A/Ssponsored adr | $18,251,000 | -19.4% | 960,600 | 0.0% | 0.16% | -27.6% | |
| CYNA | CYNAPSUS THERAPEUTICS INC | $17,604,000 | -4.5% | 1,140,325 | 0.0% | 0.16% | -14.5% | |
| SYK | STRYKER CORP | $17,287,000 | -1.2% | 186,000 | 0.0% | 0.16% | -11.3% | |
| PIRS | PIERIS PHARMACEUTICALS INC | $16,625,000 | +25.1% | 7,259,620 | 0.0% | 0.15% | +12.7% | |
| ENTA | New | ENANTA PHARMACEUTICALS INC | $16,652,000 | – | 504,300 | +100.0% | 0.15% | – |
| XNCR | Sell | XENCOR INC | $16,185,000 | +17.1% | 1,107,022 | -2.0% | 0.15% | +5.0% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $15,609,000 | -21.2% | 149,000 | -20.7% | 0.14% | -29.5% |
| SVA | SINOVAC BIOTECH LTD | $15,258,000 | +12.6% | 2,667,500 | 0.0% | 0.14% | +0.7% | |
| ZBH | Sell | ZIMMER BIOMET HLDGS INC | $15,060,000 | -24.5% | 146,800 | -30.9% | 0.14% | -32.3% |
| GLPG | Sell | GALAPAGOS NVspon adr | $14,462,000 | -30.7% | 230,000 | -55.2% | 0.13% | -37.9% |
| NTRA | NATERA INC | $13,783,000 | -0.5% | 1,276,190 | 0.0% | 0.12% | -10.7% | |
| CAH | CARDINAL HEALTH INC | $13,033,000 | +16.2% | 146,000 | 0.0% | 0.12% | +4.4% | |
| SGYPQ | SYNERGY PHARMACEUTICALS DEL | $12,909,000 | +7.0% | 2,276,648 | 0.0% | 0.12% | -4.1% | |
| EHTH | EHEALTH INC | $12,974,000 | -22.1% | 1,300,000 | 0.0% | 0.12% | -30.4% | |
| JAZZ | Sell | JAZZ PHARMACEUTICALS PLC | $12,650,000 | -17.2% | 90,000 | -21.7% | 0.12% | -25.3% |
| NBRV | NABRIVA THERAPEUTICS AGsponsored adr | $12,650,000 | +1.3% | 1,315,000 | 0.0% | 0.12% | -8.7% | |
| IMMU | Buy | IMMUNOMEDICS INC | $11,672,000 | +104.2% | 3,802,000 | +14.4% | 0.11% | +82.8% |
| BXLT | BAXALTA INC | $11,124,000 | +23.9% | 285,000 | 0.0% | 0.10% | +11.0% | |
| ENSG | Buy | ENSIGN GROUP INC | $11,206,000 | +6.2% | 495,200 | +100.0% | 0.10% | -5.6% |
| CLLS | CELLECTIS S Asponsored ads | $10,861,000 | +17.7% | 350,000 | 0.0% | 0.10% | +5.4% | |
| ASMB | ASSEMBLY BIOSCIENCES INC | $10,492,000 | -21.4% | 1,397,100 | 0.0% | 0.10% | -29.6% | |
| MGNX | MACROGENICS INC | $9,817,000 | +44.6% | 317,000 | 0.0% | 0.09% | +29.0% | |
| ABT | ABBOTT LABS | $9,476,000 | +11.7% | 211,000 | 0.0% | 0.09% | 0.0% | |
| INCYTE CORPnote 1.250%11/1 | $9,292,000 | -1.2% | 4,250,000 | 0.0% | 0.08% | -11.6% | ||
| INCYTE CORPnote 0.375%11/1 | $9,195,000 | +2.4% | 4,250,000 | 0.0% | 0.08% | -8.8% | ||
| VTAE | Buy | VITAE PHARMACEUTICALS INC | $8,822,000 | +121.7% | 487,400 | +34.8% | 0.08% | +100.0% |
| SIEN | Sell | SIENTRA INC | $8,036,000 | -73.4% | 1,357,500 | -54.4% | 0.07% | -76.1% |
| LBIO | LION BIOTECHNOLOGIES INC | $7,891,000 | +34.0% | 1,022,100 | 0.0% | 0.07% | +20.3% | |
| MDVN | New | MEDIVATION INC | $7,879,000 | – | 163,000 | +100.0% | 0.07% | – |
| MRNS | New | MARINUS PHARMACEUTICALS INC | $7,373,000 | – | 965,000 | +100.0% | 0.07% | – |
| RDHL | REDHILL BIOPHARMA LTDsponsored ads | $7,276,000 | -0.2% | 564,900 | 0.0% | 0.07% | -10.8% | |
| AET | AETNA INC NEW | $7,244,000 | -1.2% | 67,000 | 0.0% | 0.07% | -10.8% | |
| FLUIDIGM CORP DELnote 2.750% 2/0 | $6,424,000 | -10.2% | 10,000,000 | 0.0% | 0.06% | -19.4% | ||
| ADXS | ADVAXIS INC | $6,404,000 | -1.7% | 636,600 | 0.0% | 0.06% | -12.1% | |
| CNXR | CONNECTURE INC | $6,281,000 | -20.8% | 1,740,000 | 0.0% | 0.06% | -28.8% | |
| ANAC | ANACOR PHARMACEUTICALS INC | $6,021,000 | -4.0% | 53,300 | 0.0% | 0.06% | -12.7% | |
| MCRB | Sell | SERES THERAPEUTICS INC | $5,848,000 | -20.0% | 166,645 | -32.4% | 0.05% | -28.4% |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $5,292,000 | +150.6% | 438,784 | +148.6% | 0.05% | +128.6% |
| ITEK | INOTEK PHARMACEUTICALS CORP | $4,815,000 | +20.5% | 425,000 | 0.0% | 0.04% | +10.0% | |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $4,071,000 | +3.5% | 222,223 | 0.0% | 0.04% | -7.5% | |
| ROKA | ROKA BIOSCIENCE INC | $3,961,000 | -36.9% | 3,220,429 | 0.0% | 0.04% | -42.9% | |
| BITI | BIOTIE THERAPIES OYJsponsored adr | $3,855,000 | +9.6% | 268,672 | 0.0% | 0.04% | -2.8% | |
| NVTA | INVITAE CORP | $3,749,000 | +13.7% | 456,666 | 0.0% | 0.03% | +3.0% | |
| ALIM | ALIMERA SCIENCES INC | $3,630,000 | +9.5% | 1,500,000 | 0.0% | 0.03% | 0.0% | |
| PTX | PERNIX THERAPEUTICS HLDGS IN | $3,165,000 | -6.7% | 1,073,000 | 0.0% | 0.03% | -14.7% | |
| OREXIGEN THERAPEUTICS INCnote 2.750%12/0 | $3,104,000 | -14.3% | 5,210,000 | 0.0% | 0.03% | -24.3% | ||
| FATE | FATE THERAPEUTICS INC | $2,335,000 | -36.8% | 692,900 | 0.0% | 0.02% | -43.2% | |
| ADRO | Sell | ADURO BIOTECH INC | $1,688,000 | -91.8% | 60,000 | -94.4% | 0.02% | -92.8% |
| OCUL | Sell | OCULAR THERAPEUTIX INC | $1,452,000 | -50.6% | 155,000 | -25.8% | 0.01% | -56.7% |
| XTNT | XTANT MED HLDGS INC | $1,331,000 | -14.1% | 475,439 | 0.0% | 0.01% | -25.0% | |
| QLTI | QLT INC | $1,330,000 | 0.0% | 500,000 | 0.0% | 0.01% | -7.7% | |
| BLRX | BIOLINERX LTDsponsored adr | $1,350,000 | -15.0% | 1,038,600 | 0.0% | 0.01% | -25.0% | |
| CGNT | COGENTIX MED INC | $1,278,000 | +4.0% | 990,745 | 0.0% | 0.01% | 0.0% | |
| MRTX | Sell | MIRATI THERAPEUTICS INC | $1,018,000 | -87.7% | 32,200 | -86.6% | 0.01% | -89.2% |
| MNKD | MANNKIND CORPput | $653,000 | -54.8% | 450,000 | 0.0% | 0.01% | -60.0% | |
| BIOMARIN PHARMACEUTICAL INCnote 0.750%10/1 | $645,000 | -1.2% | 500,000 | 0.0% | 0.01% | -14.3% | ||
| AMRN | AMARIN CORP PLCspons adr new | $662,000 | -2.1% | 350,000 | 0.0% | 0.01% | -14.3% | |
| BIOMARIN PHARMACEUTICAL INCnote 1.500%10/1 | $672,000 | +2.9% | 500,000 | 0.0% | 0.01% | -14.3% | ||
| ALIM | ALIMERA SCIENCES INCcall | $484,000 | +9.5% | 200,000 | 0.0% | 0.00% | 0.0% | |
| MDGS | MEDIGUS LTDsponsored adr | $52,000 | -98.1% | 600,000 | 0.0% | 0.00% | -100.0% | |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -204,000 | -100.0% | -0.04% | – |
| SAGE | Exit | SAGE THERAPEUTICS INC | $0 | – | -149,999 | -100.0% | -0.06% | – |
| BAX | Exit | BAXTER INTL INC | $0 | – | -319,000 | -100.0% | -0.11% | – |
| HNT | Exit | HEALTH NET INCcall | $0 | – | -250,000 | -100.0% | -0.15% | – |
| MRK | Exit | MERCK & CO INC NEW | $0 | – | -415,000 | -100.0% | -0.21% | – |
| DYAX | Exit | DYAX CORP | $0 | – | -1,117,000 | -100.0% | -0.22% | – |
| EXAS | Exit | EXACT SCIENCES CORP | $0 | – | -1,778,000 | -100.0% | -0.32% | – |
| CMRX | Exit | CHIMERIX INC | $0 | – | -1,021,600 | -100.0% | -0.39% | – |
| T107PS | Exit | WRIGHT MED GROUP INC | $0 | – | -8,142,000 | -100.0% | -1.68% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-16
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOGEN INC | 42 | Q3 2023 | 5.0% |
| VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
| THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
| SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
| NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
| BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
| BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
| AMGEN INC | 40 | Q3 2023 | 5.5% |
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
| GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
| Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
| PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
| Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
| Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
| Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
| Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
| VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
| Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
| Verona Pharma plc | May 16, 2023 | 3,777,778 | 4.8% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-26 |
| 4 | 2024-04-23 |
| 4 | 2024-04-18 |
| 4 | 2024-04-15 |
| 3/A | 2024-04-12 |
| SC 13D/A | 2024-04-12 |
| 4 | 2024-04-05 |
| SC 13D/A | 2024-04-04 |
| 3 | 2024-04-03 |
| SC 13D | 2024-03-28 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.